Thursday, March 22, 2007

Implicit Bioscience Sets Up Seattle Office

Brisbane, Australia-based Implicit Bioscience Pty Ltd., which is developing biopharmaceuticals for the treatment of hepatitis C infection, said today that it is moving its U.S. operations to Seattle. Implicit said that it has appointed Timothy Axtelle as Vice President, Research and Development as part of the move. Axtelle was most recently Director, Therapeutic Development at ICOS Corporation.